Market revenue in 2024 | USD 6.1 million |
Market revenue in 2030 | USD 10.3 million |
Growth rate | 9.2% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 70.49% in 2024. Horizon Databook has segmented the Chile deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
High prevalence of mental disorders in Chile is a major factor driving the market growth over the forecast period. However, low healthcare expenditure in the country often restricts entry of new or local players in the market, as the scope for growth is very limited. Furthermore, limited number of hospitals and clinics in Chile is expected to lower the demand for deep brain stimulation devices.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account